Orthofix Medical Inc
$ 11.79
-3.12%
30 Jul - close price
- Market Cap 491,932,000 USD
- Current Price $ 11.79
- High / Low $ 12.14 / 11.62
- Stock P/E N/A
- Book Value 10.78
- EPS -1.49
- Next Earning Report 2026-08-05
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.03 %
- ROE -0.13 %
- 52 Week High 16.99
- 52 Week Low 8.85
About
Orthofix Medical Inc. is a medical device and biological products company in the United States, Italy, Germany, the United Kingdom, Brazil, and internationally. The company is headquartered in Lewisville, Texas.
Analyst Target Price
$15.50
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-05 | 2026-02-24 | 2025-11-04 | 2025-08-05 | 2025-05-06 | 2025-02-25 | 2024-11-07 | 2024-08-06 | 2024-05-07 | 2024-03-05 | 2023-11-08 | 2023-08-08 |
| Reported EPS | -0.11 | 0.2378 | 0.2 | 0.13 | -0.03 | 0.0154 | 0.07 | 0.05 | 0.11 | 0.03 | 0.07 | 0.02 |
| Estimated EPS | -0.29 | -0.22 | 0.12 | 0.04 | -0.27 | -0.05 | -0.15 | -0.19 | -0.33 | -0.08 | -0.21 | -0.47 |
| Surprise | 0.18 | 0.4578 | 0.08 | 0.09 | 0.24 | 0.0654 | 0.22 | 0.24 | 0.44 | 0.11 | 0.28 | 0.49 |
| Surprise Percentage | 62.069% | 208.0909% | 66.6667% | 225% | 88.8889% | 130.8% | 146.6667% | 126.3158% | 133.3333% | 137.5% | 133.3333% | 104.2553% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-05 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | -0.46 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: OFIX
2026-07-29 10:00:00
Analysts expect Orthofix (OFIX) to report a year-over-year decline in earnings for the quarter ended June 2026, despite anticipating higher revenues. The company is projected to post a quarterly loss of $0.03 per share on revenues of $209.51 million. While the stock currently holds a Zacks Rank #2, its Earnings ESP of 0% suggests it's difficult to conclusively predict an earnings beat.
2026-07-29 04:11:28
The article analyzes the institutional confidence in Orthofix Medical Inc (OFIX), highlighting its strong position in the Healthcare Equipment & Supplies industry. With an institutional shareholding score of 10.00, OFIX ranks highly, and its institutional shareholding proportion has increased by 4.24% quarter-over-quarter. Key institutional shareholders and changes in their holdings are also detailed.
2026-07-28 02:09:16
This article provides a comprehensive financial overview of Orthofix Medical Inc (OFIX), focusing on its cash flow statements. It details quarterly and annual data for operating, investing, and financing cash flows, including specific figures for net income, capital expenditures, and debt activities. The report also addresses frequently asked questions regarding cash flow components and their significance for OFIX.
2026-07-27 23:15:34
Orthofix Medical (NASDAQ:OFIX) is back in focus following a Medicare policy reversal regarding the classification of non-invasive bone growth stimulators. This shift is significant for the small-cap spine and orthopedics maker, particularly for its bone growth therapies which are a key product line within its spine business. The article highlights Orthofix Medical's opportunity to capitalize on this change within the medical device sector.
2026-07-25 07:43:25
This article details the shareholder structure of Orthofix Medical Inc (OFIX), listing its major shareholders and their respective proportions. It also breaks down shareholder types and provides institutional shareholding data over several quarters. Key shareholders include Engine Capital Management, LP and Juniper Investment Company, LLC.
2026-07-25 04:43:26
Orthofix Medical Inc (OFIX) has a stable financial status with high operating efficiency, reflected in its current financial score of 7.44, ranking 83rd in its industry. The company reported a 1.58% year-over-year increase in quarterly revenue to $196.71M and a substantial 60.62% increase in net profit year-over-year. Key areas like Quality of Earnings, Operational Efficiency, Growth Potential, and Shareholder Returns also show positive scores.
